Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
09/2003
09/24/2003CN1122022C Substituted oximes as neurokinin antagonists
09/23/2003USRE38257 Piperdine derivatives and hypotensives containing the same
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624306 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
09/23/2003US6624303 By reacting the corresponding NH-amides with acetylenes in the liquid phase using a basic alkali metal compound as catalyst and as cocatalyst (di- or tri-)1,4-butanediol mono- and diethers; N-vinyl-2-pyrrolidone from pyrrolidone
09/23/2003US6624169 Urokinase inhibitors
09/18/2003WO2003076478A1 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076403A1 1,2-disubstituded-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof
09/18/2003WO2003076402A1 Therapeutic agent for pain
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075916A1 A non-hormonal approach to male contraception
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003049681A3 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
09/18/2003WO2003029340A3 Fluorescent pigment composition
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176713 Process for the production of sulfonic esters
09/18/2003US20030176711 Process for the production of sulfonic esters
09/18/2003US20030176706 Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate]
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176693 Diphenylalkylamine derivatives useful as opioid receptor agonists
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176464 Phenyl substituted 4-hydroxy tetrahydroxypyridone
09/18/2003US20030176462 Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders
09/18/2003US20030176461 Aminopiperidines
09/18/2003US20030176460 Piperidine compounds for use as ccr-3 inhibitors
09/18/2003US20030172471 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2479027A1 A non-hormonal approach to male contraception
09/18/2003CA2478897A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343762A1 New process for the preparation diaryl-4-amino-piperidinyl compounds
09/17/2003EP1343761A1 Piperidine mch antagonists and their use in the treatment of obesity
09/17/2003EP1343760A2 Muscarinic antagonists
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1244452B1 Carboxamide derivates of pyrrolidine and piperidine as urotensin-ii receptor antagonists
09/17/2003EP1105132B1 The use of r(+)-g(a)-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of obstructive sleep apnea
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/17/2003EP0950051B1 Micro-particulate form of a tetrahydropyridin derivative
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443166A 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3, 4-diol
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/17/2003CN1442407A Chemical resolution preparation method of optically pure fesufenadin and its hydrochloride salt
09/17/2003CN1121402C Crystals of piperdine derivatives, intermediates for production of same, and process for producing the same
09/17/2003CN1121388C Process for prepn. of ropivacaine hydrochloride monohydrate
09/17/2003CN1121387C Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
09/17/2003CN1121386C Chemical process for reduction of 1-substituted-3-hydroxymethy1-4-(4-fluorophenyl)
09/16/2003CA2274133C Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
09/16/2003CA2142610C Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
09/16/2003CA2085802C 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl) -2,3-pyridinedicarboxylic acids
09/16/2003CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives
09/16/2003CA2025490C Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
09/12/2003WO2003075091A1 Colour photographic recording material
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
09/12/2003WO2003045942A3 Chemokine receptor antagonists and methods of use thereof
09/12/2003WO2002022550A3 Chiral amino alcohols and process for preparation of same
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003US20030171590 Preparation of terfenadine carboxylate metabolite and carebastine derivatives with reduced side effects
09/11/2003US20030171588 And 3-carboxylic acids and derivatives; preparation from a resin bound aldehyde or diamine
09/11/2003US20030171461 Process for the synthesis of amine ethers from secondary amino oxides
09/11/2003US20030171440 Tramadol analogs and uses thereof
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171370 Phenoxyalkylamine derivatives useful as opioid receptor agonists
09/11/2003US20030171362 Amino-tetralin derivatives as muscarinic receptor antagonists
09/11/2003US20030171349 Novel muscarinic receptor agonists
09/11/2003US20030171213 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an
09/11/2003US20030170728 Synthetic opiods; analgesics; induction of polyclonal antibodies
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1342718A1 Method and reagents for n-alkylating ureides
09/10/2003EP1341763A2 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
09/10/2003EP1341762A1 Process for resolving racemic mixtures of piperidine derivatives
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1157987B1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
09/10/2003EP0874822B1 New manufacturing process
09/10/2003EP0809647B1 Chiral organometallic compounds
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441780A Piperidine compounds for use as CCR-3 inhibitors
09/09/2003US6617454 Process for the preparation of amine oxides
09/09/2003US6617325 Biphenyl derivatives, production thereof and uses as medicines
09/09/2003US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril
09/09/2003US6617320 Protease inhibitor; anticoagulants